142 related articles for article (PubMed ID: 25314009)
1. Factors predict prolonged wait time and longer duration of radiotherapy in patients with nasopharyngeal carcinoma: a multilevel analysis.
Chen PC; Yang CC; Wu CJ; Liu WS; Huang WL; Lee CC
PLoS One; 2014; 9(10):e109930. PubMed ID: 25314009
[TBL] [Abstract][Full Text] [Related]
2. The impact of time factors on overall survival in patients with nasopharyngeal carcinoma: a population-based study.
Chen PC; Liu WS; Huang WL; Wu CJ; Yang CC; Lee CC
Radiat Oncol; 2016 Apr; 11():62. PubMed ID: 27117713
[TBL] [Abstract][Full Text] [Related]
3. Comparison the clinical outcomes with altered versus conventional fractionated radiotherapy plus concurrent chemotherapy for advanced nasopharyngeal carcinoma.
Lin PJ; Twu CW; Liu YC; Lin TY; Wang WY; Lin JC
Head Neck; 2018 Jun; 40(6):1156-1163. PubMed ID: 29389048
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy.
Wei Y; Zhou T; Zhu J; Zhang Y; Sun M; Ding X; Wang D; Li H; Li B
Cell Biochem Biophys; 2014 Jul; 69(3):433-7. PubMed ID: 24510513
[TBL] [Abstract][Full Text] [Related]
5. Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study.
Hong RL; Hsiao CF; Ting LL; Ko JY; Wang CW; Chang JTC; Lou PJ; Wang HM; Tsai MH; Lai SC; Liu TW
Ann Oncol; 2018 Sep; 29(9):1972-1979. PubMed ID: 30016391
[TBL] [Abstract][Full Text] [Related]
6. Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5 year follow-up.
Wu SY; Wu YH; Yang MW; Hsueh WT; Hsiao JR; Tsai ST; Chang KY; Chang JS; Yen CJ
BMC Cancer; 2014 Oct; 14():787. PubMed ID: 25351202
[TBL] [Abstract][Full Text] [Related]
7. Nasopharyngeal carcinoma: Experience and treatment outcome with radical conformal radiotherapy from a tertiary care center in India.
Kunheri B; Agarwal G; Sunil PS; Nair AR; Pushpaja KU
Indian J Cancer; 2017; 54(3):502-507. PubMed ID: 29798947
[TBL] [Abstract][Full Text] [Related]
8. Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma.
Lee AW; Ngan RK; Tung SY; Cheng A; Kwong DL; Lu TX; Chan AT; Chan LL; Yiu H; Ng WT; Wong F; Yuen KT; Yau S; Cheung FY; Chan OS; Choi H; Chappell R
Cancer; 2015 Apr; 121(8):1328-38. PubMed ID: 25529384
[TBL] [Abstract][Full Text] [Related]
9. The detrimental effects of radiotherapy interruption on local control after concurrent chemoradiotherapy for advanced T-stage nasopharyngeal carcinoma: an observational, prospective analysis.
Yao JJ; Jin YN; Wang SY; Zhang F; Zhou GQ; Zhang WJ; Zhi-Bin ; Cheng ; Ma J; Qi ZY; Sun Y
BMC Cancer; 2018 Jul; 18(1):740. PubMed ID: 30012115
[TBL] [Abstract][Full Text] [Related]
10. Role of sequential chemoradiotherapy in stage II and low-risk stage III-IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: A propensity score-matched analysis.
Xu C; Sun R; Tang LL; Chen L; Li WF; Mao YP; Zhou GQ; Guo R; Lin AH; Sun Y; Ma J; Hu WH
Oral Oncol; 2018 Mar; 78():37-45. PubMed ID: 29496056
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma.
Yi J; Huang X; Gao L; Luo J; Zhang S; Wang K; Qu Y; Xiao J; Xu G
Radiat Oncol; 2014 Feb; 9():56. PubMed ID: 24533569
[TBL] [Abstract][Full Text] [Related]
12. Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials.
Lee AW; Tung SY; Ngan RK; Chappell R; Chua DT; Lu TX; Siu L; Tan T; Chan LK; Ng WT; Leung TW; Fu YT; Au GK; Zhao C; O'Sullivan B; Tan EH; Lau WH
Eur J Cancer; 2011 Mar; 47(5):656-66. PubMed ID: 21112774
[TBL] [Abstract][Full Text] [Related]
13. Dose delivery analysis of weekly versus 3-weekly cisplatin concurrent with radiation therapy for locally advanced nasopharyngeal carcinoma (NPC).
Jagdis A; Laskin J; Hao D; Hay J; Wu J; Ho C
Am J Clin Oncol; 2014 Feb; 37(1):63-9. PubMed ID: 23111356
[TBL] [Abstract][Full Text] [Related]
14. A prospective study: current problems in radiotherapy for nasopharyngeal carcinoma in yogyakarta, indonesia.
Stoker SD; Wildeman MA; Fles R; Indrasari SR; Herdini C; Wildeman PL; van Diessen JN; Tjokronagoro M; Tan IB
PLoS One; 2014; 9(1):e85959. PubMed ID: 24465811
[TBL] [Abstract][Full Text] [Related]
15. The role of adjuvant chemotherapy in nasopharyngeal carcinoma with bulky neck lymph nodes in the era of IMRT.
Xu T; Shen C; Ou X; He X; Ying H; Hu C
Oncotarget; 2016 Apr; 7(15):21013-22. PubMed ID: 26942700
[TBL] [Abstract][Full Text] [Related]
16. Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter study.
Zhang B; Hu Y; Xiong RH; Pan YF; Xu QL; Kong XY; Cai R; Chen QQ; Tang HY; Jiang W
Oncotarget; 2017 Feb; 8(8):14078-14088. PubMed ID: 27845907
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy with neoadjuvant chemotherapy versus concurrent chemoradiotherapy for ascending-type nasopharyngeal carcinoma: a retrospective comparison of toxicity and prognosis.
Yao JJ; Yu XL; Zhang F; Zhang WJ; Zhou GQ; Tang LL; Mao YP; Chen L; Ma J; Sun Y
Chin J Cancer; 2017 Mar; 36(1):26. PubMed ID: 28264724
[TBL] [Abstract][Full Text] [Related]
18. Fractionated stereotactic radiotherapy with vagina carotica protection technique for local residual nasopharyngeal carcinoma after primary radiotherapy.
Liu F; Xiao JP; Xu YJ; Zhang Y; Xu GZ; Gao L; Yi JL; Luo JW; Huang XD; Huan FK; Fang H; Wan B; Li YX
Chin Med J (Engl); 2012 Jul; 125(14):2525-9. PubMed ID: 22882934
[TBL] [Abstract][Full Text] [Related]
19. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
Wei Z; Zhang Z; Luo J; Li N; Peng X
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162
[TBL] [Abstract][Full Text] [Related]
20. Concurrent chemoradiotherapy degrades the quality of life of patients with stage II nasopharyngeal carcinoma as compared to radiotherapy.
Pan XB; Huang ST; Chen KH; Jiang YM; Ma JL; Qu S; Li L; Chen L; Zhu XD
Oncotarget; 2017 Feb; 8(8):14029-14038. PubMed ID: 28152511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
